Functionally modified gelatin microspheres impregnated collagen scaffold as novel wound dressing to attenuate the proteases and bacterial growth

European Journal of Pharmaceutical Sciences

Volumn 36, Issue 2-3, 2009, Pages 235-245

  Adhirajan, N ^a   Shanmugasundaram, N ^a   Shanmuganathan, S ^b   Babu, Mary ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Collagen; Gelatin microspheres; Matrix metalloproteinase; Wound dressing; Wound healing

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; CALCEIN; COLLAGEN; DOXYCYCLINE; GELATIN; GELATINASE A; GELATINASE B; MICROSPHERE; PROTEINASE;

ARTICLE; BACTERIAL GROWTH; BIOCOMPATIBILITY; CROSS LINKING; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WOUND DRESSING; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; BANDAGES; BIOLOGICAL AVAILABILITY; CATECHOLS; CATTLE; CELL SURVIVAL; COLLAGEN; DOXYCYCLINE; DRUG DELIVERY SYSTEMS; FERROUS COMPOUNDS; FIBROBLASTS; FOOT ULCER; GELATIN; HUMANS; MATERIALS TESTING; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; PROTEASE INHIBITORS; WATER; WOUND HEALING;

EID: 58149235009     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.09.010     Document Type: Article

References (32)

1. Adhirajan N., Shanmugasundaram N., and Babu M. Gelatin microspheres crosslinked with EDC as a drug delivery system for doxycycline: development and characterization. J. Microencapsul. 24 (2007) 659-671
2. Bernkop-Schnurch A., and Kast C.E. Chemically modified chitosan as enzyme inhibitors. Adv. Drug Deliv. Rev. 52 (2001) 27-137
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
4. Bubins W.A., and Ofner C.M. The determination of ε-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzenesulfonic acid. Anal. Biochem. 207 (1992) 129-133
5. Cullen B., Smith R., McCulloch E., Silcock D., and Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen. 10 (2002) 16-25
6. Esposito E., Cortesi R., and Nastruzzi C. Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials 17 (1996) 2009-2020
7. Fass R.J., and Barnishan J. Minimal inhibitory concentrations of 34 antimicrobial agents for control strains Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853. Antimicrob. Agents Chemother. 16 (1979) 622-624
8. Franz T.J. The finite dose technique as a valid in vitro model for the study of percutaneous absorption in man. Curr. Probl. Dermatol. 7 (1978) 58-68
9. Gendron R., Grenier D., Sorsa T., Uitto V.J., and Mayrand D. Effect of microbial siderophores on matrix metalloproteinase-2 activity. J. Periodontal. Res. 34 (1999) 50-53
10. Kosasih A., Bowman B.J., Wigent R.J., and Ofner III C.M. Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables. Int. J. Pharm. 204 (2000) 81-89
11. Kuijpers A.J., Engbers G.H., Kriigsveld J., Zaat S.A., Dankert J., and Feijen J. Cross-linking and characterisation of gelatin matrices for biomedical applications. J. Biomater. Sci. Polym. Ed. 11 (2000) 225-243
12. Kumar T.R., Shanmugasundaram N., and Babu M. Biocompatible collagen scaffolds from a human amniotic membrane: Physiochemical and in vitro culture characteristics. J. Biomater. Sci. Polym. Ed. 14 (2003) 689-706
13. Meaume S., Vallet D., Morere M.N., and Teot L. Evaluation of a silver releasing hydroalginate dressing in chronic wounds with signs of local infection. J. Wound Care 14 (2005) 411-419
14. Mi F.L., Wu Y.B., Shyu S.S., Schoung J.Y., Huang Y.B., Tsai Y.H., and Hao J.Y. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J. Biomed. Mater. Res. 59 (2002) 438-449
15. Morimoto K., Chono S., Kosai T., Seki T., and Tabata Y. Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs. Drug Deliv. 15 (2008) 113-117
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
17. Narayani R., and Rao K.P. Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres. J. Microencapsul. 11 (1994) 69-77
18. National Committee for Clinical Lab Standards (NCCLS), 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacterial that Grow Aerobically; Approved Standard, fifth ed., vol. 20, no. 2, M7-A5.
19. Olde Damink L.H.H., Dijkstra P.J., Van Luyn M.J.A., Van Wachem P.B., Nieuwenhuis P., and Feijen J. Crosslinking of dermal sheep collagen using water-soluble carbodiimide. Biomaterials 17 (1996) 765-773
20. Rayment R.A., Dargaville T.R., Shooter G.K., George G.A., and Upton Z. Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels. Biomaterials 29 (2008) 1785-1795
21. Schönfelder U., Abel M., Wiegand C., Klemm D., Elsner P., and Hipler U.C. Influence of selected wound dressings on PMN elastase in chronic wound fluid and their antioxidative potential in vitro. Biomaterials 26 (2005) 6664-6673
22. Schultz G.S., and Mast B.A. Molecular analysis of the environment of healing and chronic wounds: cytokines, proteases and growth factors. Wounds 10 (1998) 1F-9F
23. Shanmugasundaram N., Sundaraseelan J., Uma S., Selvaraj D., and Babu M. Design and delivery of silver sulfadiazine from alginate microspheres-impregnated collagen scaffold. J. Biomed. Mater. Res. B Appl. Biomater. 77B (2006) 378-388
24. Sripriya R., Senthil Kumar M., and Sehgal P.K. Improved collagen bilayer dressing for the controlled release of drugs. J. Biomed. Mater. Res. B Appl. Biomater. 70B (2004) 389-396
25. Tabata Y., Hijikata S., and Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J. Control. Release 31 (1994) 111-214
26. Temperini C., Innocenti A., Scozzafava A., and Supuran C.T. N-hydroxyurea-a versatile zinc binding function in the design of metalloenzyme inhibitors. Bioorg. Med. Chem. Lett. 16 (2006) 4316-4320
27. Tsipouras N., Rix C.J., and Brady P.H. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream. Clin. Chem. 41 (1995) 87-91
28. Vachon D.J., and Yager D.R. Novel sulfonated hydrogel composite with the ability to inhibit proteases and bacterial growth. J. Biomed. Mater. Res. A 76 (2006) 35-43
29. Vincenti M.P., Clark I.M., and Brinckerhoff C.E. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?. Arthritis Rheum. 37 (1994) 1115-1126
30. Wang J., Tabata Y., and Morimoto K. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J. Control. Release 113 (2006) 31-37
31. Wenk J., Achterberg V., Sabiwalsky A., Dissemond J., Meewes G., and Reitz A. Selective pick up of increased iron by deferoxamine coupled cellulose abrogates the iron driven induction of matrix degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: a new dressing concept. J. Invest. Dermatol. 116 (2001) 833-839
32. Wysocki A.B., Staiano-Coico L., and Grinnel F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP 2 and MMP 9. J. Invest. Dermatol. 101 (1993) 64-68